Astronics Corp (ATRO) Provides Surprising 2016 Revenue Guidance Following In-Line 3Q; Canaccord Genuity Reiterates Buy
Get Alerts ATRO Hot Sheet
Rating Summary:
6 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Join SI Premium – FREE
Canaccord Genuity maintained a Buy rating on Astronics (NASDAQ: ATRO), and cut the price target to $56.00 (from $60.00), following the company's 3Q earnings report. Astronics (ATRO) reported EPS of $0.94 and revenues of $200.1M, in-line with consensus. Most of the growth in the aerospace segment came from increased sales in Electrical Power & Motion, up 15%, with sales of in-seat power providing the bulk of this growth. The company provided initial 2016 revenue guidance of sales in the $690M to $750M range, which implies up 6%-10% in the Aerospace segment
Analyst Ken Herbert commented, "Revenues at $200.1M were basically in line with guidance, but the better than expected earnings were driven by margins in both the aerospace and test businesses. In a surprise move, the company provided initial 2016 revenue guidance of sales in the $690M to $750M range, which implies up 6%-10% in the Aerospace segment, but down ~10% in the Test segment. We like the confidence in the initial 2016 outlook, and we believe it does help to overcome some concerns in the test business, even with aerospace growth again in the high single digits."
For an analyst ratings summary and ratings history on Astronics click here. For more ratings news on Astronics click here.
Shares of Astronics closed at $42.48 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Comerica (CMA) PT Raised to $54 at Piper Sandler
- Intuitive Surgical (ISRG) PT Raised to $435 at Piper Sandler
- Linamar Corp. (LNR:CN) (LIMAF) PT Lowered to Cdn$90 at CIBC
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Earnings, Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!